Atherosclerosis treatment to prevent CVD

Tue, 08/13/2013 - 08:45 |

content manager

Video:

This presentation is part of the Peptide Showcase at Boulder Peptide Symposium: browse our YouTube Channel or go to www.boulderpeptide.org.

Artery Therapeutics, a biotechnology company based in San Francisco, developing ApoA-I peptide mimetics for the treatment of cardiovascular disease.

Tue, 08/13/2013 - 08:45 |

content manager

Source

Rate this article

Artery Therapeutics

Related Company/Institution:

Artery Therapeutics

Antibodies, Kits, Lysates, Proteins, Peptides

General Website Search

Antibody Community

Antibody Shop

Contract Research

Help & support

Antibody News
Research and Development
Equipment and Tools
Events
Jobs
Antibody Headlines
Antibody Scout
Antibody Industry
Partnering
Tenders
Publications
Books
Journals
Education
Antibody Forum

Antigens
Primary antibodies
Secondary antibodies
Isotype Controls
Kits
Lysates
Proteins
Peptides

Search, find and buy your antibody quick and easy in our online store.

Comment, ask questions and rate the contract research services and help your colleagues.

ADCC and CDC Assays
Ab Amplification
Ab Arrays
Ab Conjugation
Ab Detection
Ab Glycosylation
Ab Humanization
Ab Purification
Custom Antibodies
Custom Peptide Synthesis
Custom Protein Expression
Epitope Mapping
Hybridomas
Immunohistochemistry

For orders and inquiries:
Phone: +31 (0)30 2270495
Fax: +31 (0)30 7521089
info [at] AntibodyChain [dot] com

For scientific support, technical questions, protocols and advice on antibodies, peptides, proteins and related products please add your questions or comments directly in the section under the product(s).

We provide you a.s.a.p with the answer and create a transparant overview in antibodies, protocols and contract research services for you and your colleagues that might have the same question(s).

Antibody Chain, the community for antibodies

Member login